Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Lam Research (LRCX, NASDAQ): To the Insiders -- Ignore unavailable to you. Want to Upgrade?

To: Proud_Infidel who wrote (3459)	10/20/1999 6:50:00 AM
From: Duker	Read Replies (3) \| Respond to of 5867

BK, My doctor has not written the prescription for the Lam enema. In fact, my doctor has been in a detox program for the last few months. I am pretty sure he will lose his prescription writing privileges. (N.B., the enema itself is quite advanced and worth mentioning. It is the latest in Copper-based enemas. This technology replaces the industry standard Barium enemas. Cu offers the advantages of increased speed to cleansing, but requires a few more process steps.) --Duker, still incredibly excited about the TSMC/TERES order.